Report
Jonathan Moreland
EUR 8.79 For Business Accounts Only

InsiderInsights Daily Ratings Report: December 7, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
Atlas Technical Consultants Inc (A)

Babcock & Wilcox Enterprises

Babcock & Wilcox Enterprises is a technology-based provider of steam production from fossil and renewable sources. The company's segments are: Babcock & Wilcox, which focuses on the supply of, and aftermarket services for, steam-generating, environmental, and auxiliary equipment for power generation and other industrial applications; Volund & Other Renewable, which provides steam-generating systems, environmental and auxiliary equipment for the waste-to-energy and biomass power generation industries, and plant operations and maintenance services for its systems and equipment; and SPIG S.p.A. (SPIG), which provides custom-engineered cooling systems, services and aftermarket products.

CERECOR INC

Cerecor is a biopharmaceutical company. The company is building a pipeline of therapies in neurology, pediatric healthcare, and orphan rare diseases. The company's neurology pipeline is led by CERC-301, which is in a Phase I safety study for Neurogenic Orthostatic Hypotension. The company is also developing two other neurological clinical and preclinical stage compounds. The company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. All three of these compounds are preclinical therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation by means of substrate replacement therapy.

Chiasma

Chiasma is a clinical-stage biopharmaceutical company focused on improving the lives of patients who face challenges related with their existing treatments for diseases. The company is evaluating oral octreotide capsules, conditionally trade-named MYCAPSSA, its sole Transient Permeability Enhancer platform-based clinical product candidate, in clinical trials in adult patients for the treatment of acromegaly to potentially support regulatory approval in the United States and European Union. The company is also conducting a clinical trial, referred to as MPOWERED, of oral octreotide capsules for the maintenance treatment of adult patients with acromegaly to support regulatory approval in the European Union.

Griffon Corporation

Griffon is a management and holding company that conducts its business through wholly-owned subsidiaries. The company's segments: Consumer and Professional Products, which manufactures and markets a portfolio of long-handled tools, landscaping products, and home organization product used by seasonal outdoor tools, project tools, outdoor decor and watering, home organization, and cleaning products categories; Home and Building Products, which manufactures a line of residential sectional garage doors; and Defense Electronics, which designs, develops, manufactures and provides logistical support and lifecycle sustainment services to defense, aerospace and commercial customers.

LIBERATED SYNDICATION

Regulus Therapeutics

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch